Impact of soy supplementation on sex steroids and vascular inflammation markers in postmenopausal women using tibolone: role of equol production capability

References

• Rexrode K M, Manson J AE, Lee I-M, et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 2003; 108: 1688–1693
   PubMed Web of Science ®Google Scholar
• Rosano G M, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence. Climacteric 2007; 10(Suppl 1)19–24
   PubMedGoogle Scholar
• Joffe H V, Ridker P M, Manson J E, Cook N R, Buring J E, Rexrode K M. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease. Ann Epidemiol 2006; 16: 105–112
   PubMed Web of Science ®Google Scholar
• Bell R J, Davison S L, Papalia M-A, McKenzie D P, Davis S R. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Menopause 2007; 14: 630–638
   PubMed Web of Science ®Google Scholar
• Davison S, Davis S R. New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab 2003; 88: 2470–2478
   PubMed Web of Science ®Google Scholar
• Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170: 191–203
   PubMed Web of Science ®Google Scholar
• Mendelsohn M E, Karas R H. HRT and the young at heart. N Engl J Med 2007; 356: 2639–2641
   PubMed Web of Science ®Google Scholar
• Manson J E, Allison M A, Rossouw J E, et al. WHI and WHI-CACS Investigators. Estrogen therapy and coronary artery calcification. N Engl J Med 2007; 356: 2591–2602
   PubMed Web of Science ®Google Scholar
• Campisi R, Marengo F D. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Cardiovasc Drug Rev 2007; 25: 132–145
   PubMed Web of Science ®Google Scholar
• Bots M L, Evans G W, Riley W, et al. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study. Eur Heart J 2006; 27: 746–755
   PubMed Web of Science ®Google Scholar
• Clarkson T B. Does tibolone exacerbate atherosclerosis?. Eur Heart J 2006; 27: 635–637
   PubMed Web of Science ®Google Scholar
• Clarkson T B. Soy, soy phytoestrogens and cardiovascular disease. J Nutr 2002; 132: 566–569S
   PubMed Web of Science ®Google Scholar
• Setchell K DR, Brown N M, Lydeking-Olsen E. The clinical importance of the metabolite equol – a clue to the effectiveness of soy and its isoflavones. J Nutr 2002; 132: 3577–3582
   PubMed Web of Science ®Google Scholar
• Atkinson C, Frankenfeld C L, Lampe J L. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med 2005; 230: 155–170
   PubMed Web of Science ®Google Scholar
• Duncan A M, Merz-Demlow B, Xu X, Phipps W R, Kurzer M S. Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2000; 9: 581–586
   PubMed Web of Science ®Google Scholar
• Frankenfeld C L, McTiernan A, Tworoger S S, et al. Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in postmenopausal women in relation to daidzein-metabolizing phenotypes. J Steroid Biochem Mol Biol 2004; 88: 399–408
   PubMed Web of Science ®Google Scholar
• Low Dog T. Menopause: a review of botanical dietary supplements. Am J Med 2005; 118: 98–108S
   PubMed Web of Science ®Google Scholar
• Wang G J, Lapcik O, Hampl R, et al. Time-resolved fluoroimmunoassay of plasma daidzein and genistein. Steroids 2000; 65: 339–348
   PubMed Web of Science ®Google Scholar
• Verheul H A, Blok L J, Burger C W, Hanifi-Moghaddam P, Kloosterboer H J. Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium and vagina of postmenopausal women treated for 21 days with tibolone, estradiol or estradiol plus medroxyprogesteroneacetate. Reprod Sci 2007; 14: 160–168
   PubMed Web of Science ®Google Scholar
• Törmälä R M, Appt S, Clarkson T B, Tikkanen M J, Ylikorkala O, Mikkola T S. Individual differences in equol production capability modulate blood pressure in tibolone treated postmenopausal women; lack of effect of soy supplementation. Climacteric 2007; 10: 471–479
   PubMed Web of Science ®Google Scholar
• Törmälä R M, Appt S, Clarkson T B, et al. Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect with soy supplementation. Atherosclerosis 2008; 198: 174–178
   PubMed Web of Science ®Google Scholar
• Mueck A O, Seeger H. Biochemical markers surrogating on vascular effects of sex steroid hormones. Gynecol Endocrinol 2006; 22: 163–173
   PubMed Web of Science ®Google Scholar
• Tham D M, Gardner C D, Haskell W L. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological and mechanistic evidence. J Clin Endocrinol Metab 1998; 83: 2223–2235
   PubMed Web of Science ®Google Scholar
• Nikander E, Metsä-Heikkilä M, Tiitinen A, Ylikorkala O. Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women. J Clin Endocrinol Metab 2003; 88: 5180–5185
   PubMed Web of Science ®Google Scholar
• Wood C E, Register T C, Cline J M. Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys. Carcinogenesis 2007; 28: 801–808
   PubMed Web of Science ®Google Scholar
• Harris R M, Wood D M, Bottomley L, et al. Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment. J Clin Endocrinol Metab 2004; 89: 1779–1787
   PubMed Web of Science ®Google Scholar
• Lewis J G, Nakajin S, Ohno S, Warnock A, Florkowski C M, Elder P A. Circulating levels of isoflavones and markers of 5alpha-reductase activity are higher in Japanese compared with New Zealand males: what is the role of circulating steroid in prostate disease?. Steroids 2005; 70: 974–979
   PubMed Web of Science ®Google Scholar
• Mikkola T S, Clarkson T B. Estrogen replacement therapy, atherosclerosis and vascular function. Cardiovasc Res 2002; 53: 605–619
   PubMed Web of Science ®Google Scholar
• Cicinelli E, Ranieri G, Maffei S, et al. Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women. Fertil Steril 2006; 86: 899–904
   PubMed Web of Science ®Google Scholar
• Sator K, Sator M O, Sator P G, Egarter C, Huber J C. Effects of tibolone on selectins in postmenopausal women. Maturitas 2006; 53: 166–170
   PubMed Web of Science ®Google Scholar
• Vafeiadou K, Hall W L, Williams C M. Does genotype and equol-production status affect response to isoflavones? Data from a pan-European study on the effects of isoflavones on cardiovascular risk markers in post-menopausal women. Proc Nutr Soc 2006; 65: 106–115
   PubMed Web of Science ®Google Scholar
• Matthan N R, Jalbert S M, Ausman L M, Kuvin J T, Karas R H, Lichtenstein A H. Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am J Clin Nutr 2007; 85: 960–966
   PubMed Web of Science ®Google Scholar